Basilea shareholders approve all proposals of the board of directors at the annual general meeting
Basel, Switzerland, April 21, 2021
Basilea Pharmaceutica Ltd. (SIX: BSLN) reported today that shareholders approved all proposals of the board of directors at today’s annual general meeting (AGM) for the financial year 2020.
In accordance with the ordinance issued by the Swiss Federal Council (COVID-19 Ordinance 3, extended until December 31, 2021) and the protective measures against the coronavirus that currently apply, the board of directors of Basilea Pharmaceutica Ltd. had decided to hold the AGM 2021 without the physical presence of shareholders. Accordingly, shareholders exercised their voting rights exclusively via the independent proxy. At the AGM, a total of 3,997,434 shareholder votes, equivalent to 30.9 percent of the share capital and 53.5 percent of the shares entitled to vote, were represented by the independent proxy.
Basilea Pharmaceutica AG: Basilea shareholders approve all proposals of the board of directors at the annual general meeting
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Basilea Pharmaceutica AG: Basilea-Aktionäre genehmigen an der Generalversammlung alle Anträge des Verwaltungsrats
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.